UCAD : Une innovation du Pr Mor Diaw pourrait transformer le diagnostic de la drépanocytose
A team of researchers from Cheikh Anta Diop University of Dakar (UCAD) has developed a rapid diagnostic tool for sickle cell disease. This advancement is presented as promising for the screening and management of this genetic disease.
The device was developed within the Laboratory of Physiology and Functional Exploitation of the Faculty of Medicine, Pharmacy and Dentistry (FMPO), under the direction of Professor Mor Diaw. It allows for the precise identification of homozygous (SS) and heterozygous (AS) forms, while determining an individual's sickle cell status.
This innovation could facilitate early detection, a major challenge in the fight against sickle cell disease, one of the most widespread genetic diseases in Africa.
The results of the work were presented on Tuesday, June 30, 2026, to the Vice-Rector in charge of Research and Partnership at UCAD, Professor Idrissa Ly, as well as to the Director of Research and Innovation, Professor Yankhouba Seydi, during a visit to the laboratory.
This meeting allowed university officials to learn about the progress made by the team whose research focuses mainly on sickle cell disease and its links with physical activity.
Through this work, Professor Mor Diaw and his team intend to contribute to the development of innovative solutions to improve the prevention, diagnosis and management of sickle cell disease, a public health issue in Senegal as well as on the African continent.
Commentaires (7)
Participer à la Discussion
Règles de la communauté
💡 Astuce : Utilisez des emojis depuis votre téléphone ou le module emoji ci-dessous. Cliquez sur GIF pour ajouter un GIF animé. Collez un lien X/Twitter, TikTok ou Instagram pour l'afficher automatiquement.
Se connecter
Commentez avec votre profil, votre photo, et soyez averti des réponses.